Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Swoger

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 12, 2014
Reply: To PMID 24530602Miguel Regueiro, Kevin E Kip, Leonard Baidoo, et al.
Digestive Diseases and Sciences|January 23, 2018
Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel DiseaseAlexis J Lukach, Melissa I Saul, Laura K Ferris, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 24, 2014
Reply: To PMID 24440221Miguel Regueiro, Kevin E Kip, Leonard Baidoo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 21, 2014
Postoperative therapy with infliximab prevents long-term Crohn's disease recurrenceMiguel Regueiro, Kevin E Kip, Leonard Baidoo, et al.
United European Gastroenterology Journal|March 28, 2017
Validation of a tool predicting important findings on computed tomography among Crohn's disease patientsShail M Govani, Akbar K Waljee, Keith E Kocher, et al.
Inflammatory Bowel Diseases|March 23, 2013
Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting systemKevin E Kip, Jason M Swoger, Lisa M Grandinetti, et al.
Inflammatory Bowel Diseases|August 22, 2015
Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective StudyJana G Hashash, Preethi Chintamaneni, Claudia M Ramos Rivers, et al.
Inflammatory Bowel Diseases|September 18, 2010
Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patientsJason M Swoger, Edward V Loftus, William J Tremaine, et al.
Inflammatory Bowel Diseases|February 26, 2011
Clinical course of Crohn's disease following treatment of lymphomaMarwa El Mourabet, Jana G Hashash, Nicholas H Sun, et al.
Inflammatory Bowel Diseases|October 19, 2016
Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active InflammationAbhik Bhattacharya, Bhavana B Rao, Ioannis E Koutroubakis, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 12, 2014
Reply: To PMID 24530602Miguel Regueiro, Kevin E Kip, Leonard Baidoo, et al.
Digestive Diseases and Sciences|January 23, 2018
Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel DiseaseAlexis J Lukach, Melissa I Saul, Laura K Ferris, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 24, 2014
Reply: To PMID 24440221Miguel Regueiro, Kevin E Kip, Leonard Baidoo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 21, 2014
Postoperative therapy with infliximab prevents long-term Crohn's disease recurrenceMiguel Regueiro, Kevin E Kip, Leonard Baidoo, et al.
United European Gastroenterology Journal|March 28, 2017
Validation of a tool predicting important findings on computed tomography among Crohn's disease patientsShail M Govani, Akbar K Waljee, Keith E Kocher, et al.
Inflammatory Bowel Diseases|March 23, 2013
Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting systemKevin E Kip, Jason M Swoger, Lisa M Grandinetti, et al.
Inflammatory Bowel Diseases|August 22, 2015
Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective StudyJana G Hashash, Preethi Chintamaneni, Claudia M Ramos Rivers, et al.
Inflammatory Bowel Diseases|September 18, 2010
Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patientsJason M Swoger, Edward V Loftus, William J Tremaine, et al.
Inflammatory Bowel Diseases|February 26, 2011
Clinical course of Crohn's disease following treatment of lymphomaMarwa El Mourabet, Jana G Hashash, Nicholas H Sun, et al.
Inflammatory Bowel Diseases|October 19, 2016
Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active InflammationAbhik Bhattacharya, Bhavana B Rao, Ioannis E Koutroubakis, et al.
Pageof 3